Literature DB >> 30119229

The human papillomavirus (HPV)-related cancer biology: An overview.

Rodrigo Pinheiro Araldi1, Thalita Araujo Sant'Ana2, Diego Grando Módolo2, Thatiana Correa de Melo3, Diva Denelle Spadacci-Morena4, Rita de Cassia Stocco2, Janete Maria Cerutti1, Edislane Barreiros de Souza5.   

Abstract

Despite the novel diagnostic methods and therapies implemented in oncology, the number of patients that succumb by the cancer remains high globally. Currently studies point out that 20-25% of all human malignancies are related to micro-organism infections. Among these cancer-related pathogens, the human papillomavirus (HPV) has a prominent position, since the virus is responsible for about 30% of all infectious agent-related cancers. Thus, an amount of cancers could be avoided by means prophylactic and/or therapeutic measures. However, these measures required a holistic comprehension about HPV-related cancer biology. Based on this, this review aims to summarize the last evidences of HPV on cancer biology (from initiation to metastasis), focus on molecular and biochemical deregulations associated with viral infection, and discuss the viral etiology in different malignancies.
Copyright © 2018. Published by Elsevier Masson SAS.

Entities:  

Keywords:  Cancer progression; HPV; Metastasis; Mutation; Oncology

Mesh:

Substances:

Year:  2018        PMID: 30119229     DOI: 10.1016/j.biopha.2018.06.149

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  26 in total

1.  Risk Factors Associated With Human Papillomavirus Infection, Cervical Cancer, and Precancerous Lesions in Large-Scale Population Screening.

Authors:  Di Yang; Jing Zhang; Xiaoli Cui; Jian Ma; Chunyan Wang; Haozhe Piao
Journal:  Front Microbiol       Date:  2022-06-30       Impact factor: 6.064

Review 2.  Enteric Virome and Carcinogenesis in the Gut.

Authors:  Cade Emlet; Mack Ruffin; Regina Lamendella
Journal:  Dig Dis Sci       Date:  2020-03       Impact factor: 3.199

Review 3.  KSHV co-infection, a new co-factor for HPV-related cervical carcinogenesis?

Authors:  Lu Dai; Mengmeng Zhao; Wei Jiang; Zhen Lin; Luis Del Valle; Zhiqiang Qin
Journal:  Am J Cancer Res       Date:  2018-11-01       Impact factor: 6.166

Review 4.  Human Papillomavirus Infections, Cervical Cancer and MicroRNAs: An Overview and Implications for Public Health.

Authors:  Michela Lucia Sammarco; Manuela Tamburro; Alessandra Pulliero; Alberto Izzotti; Giancarlo Ripabelli
Journal:  Microrna       Date:  2020

5.  Viral genome integration of canine papillomavirus 16.

Authors:  Jennifer Luff; Michelle Mader; Peter Rowland; Monica Britton; Joseph Fass; Hang Yuan
Journal:  Papillomavirus Res       Date:  2019-02-13

Review 6.  The Role of MicroRNAs in the Metastatic Process of High-Risk HPV-Induced Cancers.

Authors:  Joana M O Santos; Sara Peixoto da Silva; Natália R Costa; Rui M Gil da Costa; Rui Medeiros
Journal:  Cancers (Basel)       Date:  2018-12-05       Impact factor: 6.639

7.  Assessment of a new low-cost, PCR-based strategy for high-risk human papillomavirus DNA detection for cervical cancer prevention.

Authors:  Pedro Surriabre; Andrea Torrico; Tania Vargas; Fuantina Ugarte; Patricia Rodriguez; Véronique Fontaine
Journal:  BMC Infect Dis       Date:  2019-10-15       Impact factor: 3.090

8.  Inferring Virus-Host relationship between HPV and its host Homo sapiens using protein interaction network.

Authors:  Qurat Ul Ain Farooq; Zeeshan Shaukat; Tong Zhou; Sara Aiman; Weikang Gong; Chunhua Li
Journal:  Sci Rep       Date:  2020-05-26       Impact factor: 4.379

Review 9.  Meet the Insidious Players: Review of Viral Infections in Head and Neck Cancer Etiology with an Update on Clinical Trials.

Authors:  Lejla Mahmutović; Esma Bilajac; Altijana Hromić-Jahjefendić
Journal:  Microorganisms       Date:  2021-05-06

10.  Reciprocal transactivation of Merkel cell polyomavirus and high-risk human papillomavirus promoter activities and increased expression of their oncoproteins.

Authors:  Kashif Rasheed; Baldur Sveinbjørnsson; Ugo Moens
Journal:  Virol J       Date:  2021-07-03       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.